research Phase I-II trial of weekly bicalutamide in men with high PSA and negative biopsy
This study found that weekly low-dose bicalutamide was safe and appeared to be associated with high-grade PIN remission and favorable PSA modulation in subjects with persistently elevated PSA but negative biopsy.

